Hydrangea dulcis folium preserves β-cell mass in diabetic db/db mice

Food and Chemical Toxicology

Volumn 47, Issue 7, 2009, Pages 1685-1688

  Kim, Mi Ja ^a   Leem, Kang Hyun ^b   Kim, Hye Kyung ^c  

^a Dongduk Women's University   (South Korea)

^b Semyung University   (South Korea)

^c Hanseo University   (South Korea)

Author keywords

Cell mass; db db Mice; Glucose homeostasis; Hydrangea dulcis folium; Insulin

Indexed keywords

GLUCOSE; HYDRANGEA DULCIS FOLIUM EXTRACT; INSULIN; LIPID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYDRANGEA; HYDRANGEA DULCIS FOLIUM; HYPERGLYCEMIA; INSULIN RELEASE; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; EATING; GLUCOSE TOLERANCE TEST; HYDRANGEA; INSULIN; INSULIN-SECRETING CELLS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; PANCREAS; PLANT EXTRACTS;

HYDRANGEA; MUS;

EID: 67349085166     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.04.015     Document Type: Article

References (23)

1. Amos A.F., McCarty D.J., and Zimmet P. The rising global burden of diabetes and its complications: estimates and projection by 2010. Diabetes Med. 14 (1997) S5-S8
2. Bonner-Weir S. Life and death of the pancreatic β cells. Trends Endocrinol. Metab. 11 (2000) 375-378
3. Brown W.V. Lipoprotein disorders in diabetes mellitus. Med. Clin. North Am. 78 (1994) 143-161
4. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation. Clin. Chem. 18 (1972) 499-502
5. Howard B.V., Savage P.J., Bennion L.J., and Bennett P.H. Lipoprotein composition in diabetes mellitus. Atherosclerois 30 (1978) 153-162
6. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., Hanafusa T., Matsuzawa Y., Yamasaki Y., and Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48 (1999) 2398-2406
7. Kato M., Inaba M., Itahana H., Ohara E., Nakamura K., Uesato S., Inouye H., and Fujita T. Studies on anticoccodial constituents of crude drugs and related plants (I) isolation and biological activities of cis- and trans-febrifugine from Hydrangea macrophylla. Nat. Med. 44 (1990) 288-292
8. Kessler I.I. Mortality experience of diabetic patients. A twenty-six-year follow-up study. Am. J. Med. 51 (1971) 715-724
9. Kundsen P., Ericksson J., Lahdenperä S., Kahri J., Groop L., and Taskinen M.R. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 38 (1995) 344-350
10. Laakso M. Epidemiology of diabetic dyslipidemia. Diabetes Rev. 3 (1995) 408-422
11. Nakagiri R., Hashizume E., Kayahashi S., Sakai Y., and Kamiya T. Suppression by Hydrangea dulcis folium of D-galactosamine-induced liver injury in vitro and in vivo. Biosci. Biotechnol. Biochem. 67 (2003) 2641-2643
12. Nozawa K., Yamada M., Tsuda Y., Kawai K., and Nakajima S. Antifungal activity of oosponol, oospolactone, phyllodulcin, hydrangenol, and some other related compounds. Chem. Pharm. Bull. 29 (1981) 2689-2691
13. Poitout V., Olson L.K., and Robertson R.P. Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J. Clin. Invest. 97 (1996) 1041-1046
14. Reaven G.M. Role of insulin resistance in human diseases. Diabetes 37 (1988) 1595-1607
15. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Charles M.A., and Bennett P.H. A two-step model for development of non-insulin-dependent diabetes. Am. J. Med. 90 (1991) 229-235
16. Surwit R.S., Seldin M.F., Kuhn C.M., Cochrane C., and Feinglos M.N. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 40 (1991) 82-87
17. Taskinen M.R., Beltz W.F., and Harper I. Effects of NIDDM on very-low-density lipoprotein, triglyceride and apolipoprotein B metabolism. Diabetes 35 (1986) 1268-1277
18. Wolfram S., Raederstorff D., Preller M., Wang Y., Teixeira S.R., Riegger C., and Weber P. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 136 (2006) 2512-2518
19. Yamahara J., Matsuda H., Shimoda H., Ishikawa H., Kawamori S., Wariishi N., Harada E., Murakami N., and Yoshikawa M. Development of bioactive functions in Hydrangea dulcis folium. II. Antiulcer, antiallergy, and cholagoic effects of the extract. Yakugaku Zasshi (in Japanese) 114 (1994) 401-413
20. Yamahara J., Miki A., Tsukamoto K., Tsukamoto K., Murakami N., and Yoshikawa M. Development of bioactive functions in Hydrangea dulcis folium. IV. Inhibitory effects of phyllodulcin and hydrangenol on lipid peroxidation. Nat. Med. 49 (1995) 84-87
21. Yki-Jarvinen H. Glucose toxicity. Endocrine Rev. 13 (1992) 415-431
22. Yoshikawa M., Uchida E., Chatani N., Murakami N., and Yamahara J. New antiallergic and antimicrobial principles from Hydrangea dulcis folium. Chem. Pharm. Bull. 40 (1992) 3121-3123
23. Zhang H., Matsuda H., Kumahara A., Ito Y., Nakamura S., and Yoshikawa M. New type of anti-diabetic compounds from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae dulcis folium). Bioorg. Med. Chem. Lett. 17 (2007) 4972-4976